Abstract
Background: Assessment of severity of symptoms in patients with Multiple Sclerosis (MS) in the setting of clinical studies is usually performed using categorical clinical scales such as the EDSS. Objective measures of disease phenotype are desirable to quantitatively and sensitively assess the progression of MS. Assessment of motor phenotype dysfunction may serve as a useful surrogate marker in MS that is easy to assess even in out-patient settings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
